PHASE-II TRIALS OF CISPLATIN AND PIPERAZINEDIONE AS SINGLE AGENTS IN THE TREATMENT OF ADVANCED OR RECURRENT NON-SQUAMOUS CELL-CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY

被引：0
|
作者：
THIGPEN, JT
BLESSING, JA
FOWLER, WC
HATCH, K
机构：
[1] UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT MED,DIV ONCOL,JACKSON,MS 39216
[2] UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT OBSTET & GYNECOL,JACKSON,MS 39216
[3] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,GYNECOL ONCOL GRP,BUFFALO,NY 14263
[4] UNIV N CAROLINA,SCH MED,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,CHAPEL HILL,NC 27514
[5] UNIV ALABAMA,DIV GYNECOL ONCOL,BIRMINGHAM,AL 35294
来源：
CANCER TREATMENT REPORTS | 1986年 / 70卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1097 / 1100
页数：4
相关论文
共 50 条
  • [41] Evaluation of gemcitabine in previously treated patients with non-squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group
    Schilder, RJ
    Blessing, J
    Cohn, DE
    GYNECOLOGIC ONCOLOGY, 2005, 96 (01) : 103 - 107
  • [42] TENIPOSIDE IN SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A PHASE-II TRIAL OF THE GYNECOLOGIC ONCOLOGY GROUP
    MUSS, HB
    BUNDY, BN
    YAZIGI, R
    YORDAN, E
    CANCER TREATMENT REPORTS, 1987, 71 (09): : 873 - 874
  • [43] Phase II Trial of Bevacizumab in the Treatment of Persistent or Recurrent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
    Monk, Bradley J.
    Sill, Michael W.
    Burger, Robert A.
    Gray, Heidi J.
    Buekers, Thomas E.
    Roman, Lynda D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (07) : 1069 - 1074
  • [44] PHASE-II TRIAL OF CISPLATIN AS 1ST-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    THIGPEN, JT
    BLESSING, JA
    HOMESLEY, H
    CREASMAN, WT
    SUTTON, G
    GYNECOLOGIC ONCOLOGY, 1989, 33 (01) : 68 - 70
  • [45] Phase II trial of piroxantrone in advanced squamous cell carcinoma of the cervix - A gynecologic oncology group study
    Lincoln, S
    Blessing, JA
    McGehee, R
    Lentz, SS
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (01): : 84 - 85
  • [46] PHASE-II TRIAL OF PIPERAZINEDIONE IN PATIENTS WITH ADVANCED OR RECURRENT UTERINE SARCOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    THIGPEN, JT
    BLESSING, JA
    HOMESLEY, HD
    HACKER, N
    CURRY, SL
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1985, 8 (05): : 350 - 352
  • [47] PHASE-II TRIAL OF VINBLASTINE IN ADVANCED OVARIAN-CARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SUTTON, GP
    BLESSING, JA
    ADELSON, MD
    HANJANI, P
    INVESTIGATIONAL NEW DRUGS, 1990, 8 (04) : 377 - 379
  • [48] A PHASE-II CLINICAL-TRIAL OF DIAZIQUONE (AZQ) IN THE TREATMENT OF PATIENTS WITH RECURRENT ADENOCARCINOMA AND ADENOSQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SLAYTON, RE
    BLESSING, JA
    RETTENMAIER, M
    BALL, H
    INVESTIGATIONAL NEW DRUGS, 1989, 7 (04) : 337 - 340
  • [49] Topotecan in squamous cell carcinoma of the cervix: A phase II study of the gynecologic oncology group
    Bookman, MA
    Blessing, JA
    Hanjani, P
    Herzog, TJ
    Andersen, WA
    GYNECOLOGIC ONCOLOGY, 2000, 77 (03) : 446 - 449
  • [50] Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or nonsquamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
    Santin, A.
    Patricia, G.
    Sill, M.
    McMeekin, D.
    Leitao, M.
    Brown, J.
    Sutton, G.
    Van Le, L.
    Boardman, C.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S18 - S18
12345